Inhalers, pills or injections help most people control their asthma, but some with severe disease opt for cutting-edge surgery that "remodels" their airways to improve their breathing.
Mar 18, 2022
0
7
A new approach to managing moderate-to-severe asthma has gained interest and attention and has led to updated guidelines for patients, but studies to date have not focused on populations that face a disproportionate burden ...
Feb 27, 2022
0
30
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung ...
Dec 8, 2021
0
33
A medicine licensed to treat psoriasis worsened symptoms in patients with severe asthma, according to trial results published today in the New England Journal of Medicine.
Oct 28, 2021
0
54
A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...
Oct 28, 2021
0
84
Asthma is a lung condition that causes swelling of the airways. It can make breathing difficult and trigger coughing, wheezing and shortness of breath. It's the most common chronic disease among children, though it affects ...
Oct 1, 2021
0
10
Among Americans with severe asthma, less than half see a specialist to manage their condition, new research shows.
Jun 22, 2021
0
0
There was a substantial decrease in asthma exacerbations among Black and Hispanic patients during the COVID-19 pandemic, according to a study recently published in the Journal of Allergy and Clinical Immunology: In Practice.
Jun 3, 2021
0
2
Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents, and adults with moderate-to-severe ...
May 19, 2021
0
15
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according ...
May 19, 2021
0
3
